<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingJeffrey A. Engelman, Pasi A. Jänne, Neal I. Lindeman et al.|Science|2007Cited by 4.5k
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLCAlexa B. Turke, Pasi A. Jänne, Kreshnik Zejnullahu et al.|Cancer Cell|2010Cited by 1.1k
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody CetuximabKimio Yonesaka, Pasi A. Jänne, Kreshnik Zejnullahu et al.|Science Translational Medicine|2011Cited by 670